Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eurocine Vaccines AB | 984,500 | net | 08 Apr 2019 | tx 5+1,615,500−631,000 |
| Vicore Pharma Holding AB | 350,000 | net | 04 Jun 2020 | tx 1+350,000 |
| Xspray Pharma AB | 50,186 | net | 21 Aug 2020 | tx 7+56,186−6,000 |
| XSprayPharma AB | 5,700 | net | 28 Sept 2017 | tx 1+5,700 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2020 | GRANT_AWARD | Vicore Pharma Holding AB | 350,000 | 0.00 SEK | deriv |
| 28 Mar 2019 | SALE | Eurocine Vaccines AB | 315,500 | 0.02 SEK | deriv |
| 01 Apr 2019 | PURCHASE | Eurocine Vaccines AB | 500,000 | 0.11 SEK | |
| 07 Dec 2018 | PURCHASE | Eurocine Vaccines AB | 615,500 | 0.24 SEK | first after silence |
| 11 Sept 2018 | SALE | Xspray Pharma AB | 2,000 | 97.28 SEK | |
| 14 May 2018 | SALE | Xspray Pharma AB | 832 | 60.89 SEK | |
| 15 May 2018 | SALE | Xspray Pharma AB | 3,168 | 60.38 SEK | |
| 02 Oct 2017 | PURCHASE | Xspray Pharma AB | 4,997 | 0.00 SEK | |
| 02 Oct 2017 | PURCHASE | Xspray Pharma AB | 1,189 | 0.00 SEK | |
| 28 Sept 2017 | PURCHASE | XSprayPharma AB | 5,700 | 22.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 07 Dec 2018.